Related Experiment Video
Updated: May 20, 2026

An Immunological Model for Heterotopic Heart and Cardiac Muscle Cell Transplantation in Rats
Published on: May 8, 2020
Postoperative cardiac homograft involvement in Erdheim-Chester disease
Amulya T Siram1, Tasha Kouvatsos, Yvelisse Suarez
1Division of Endocrinology, Diabetes and Bone Diseases, Mount Sinai Medical Center, New York, NY 10029, USA. amulyasiram@gmail.com
Abstract:
Erdheim-Chester disease (ECD) is a rare multisystem disorder which is known to affect the skin, lungs, bone, pituitary gland, retroperitoneum and cardiovascular system. The case is described of a patient with ECD who had previously undergone a Ross procedure for presumed endocarditis involving the aortic valve and aortic root. The patient subsequently developed arthralgias, abdominal pain (requiring an exploratory laparotomy) and polydipsia. Furthermore, he developed progressive, symptomatic stenosis of the pulmonic homograft. A reoperative replacement of the homograft was required. The clinically suspected diagnosis of ECD was confirmed by a pathologic analysis of the explanted pulmonary homograft, and also (retrospectively) of previously resected mesenteric tissue. It is postulated that the patient may have developed ECD as a result of an immunologic reaction to the homograft tissue used for the Ross procedure.
More Related Videos
Related Concept Videos
Rheumatic Heart Disease I: Introduction
Cardiomyopathy V: Interprofessional Care
